| Dr Calvin P Fuhrmann, MD | |
|
24 Portland Rd, Kennebunk, ME 04043-6630 | |
| (207) 985-3726 | |
| (207) 985-9293 |
| Full Name | Dr Calvin P Fuhrmann |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Allergy & Immunology |
| Location | 24 Portland Rd, Kennebunk, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710099486 | NPI | - | NPPES |
| B694721 | Other | ME | HARVARD PILGRIM |
| 2321880 | Other | ME | AETNA |
| 301480099 | Medicaid | ME | |
| 027529 | Other | ME | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RA0201X | Internal Medicine - Allergy & Immunology | 014675 (Maine) | Primary |
| Entity Name | Charles A Parent Do Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578854667 PECOS PAC ID: 3577741982 Enrollment ID: O20110706000328 |
News Archive
A new purification process developed by Cook Medical for culture oil used in assisted reproduction eliminates traces of contaminants below detectable limits of 0.1 parts per million. The oil is purified by a proprietary refining technique that removes hydrocarbon impurities, which can have adverse effects on fertilization and threaten the viability of the developing embryos. The culture oil viscosity, MEA and LAL parameters remain unchanged.
Specialized Products Company (SPC), www.specialized.net, which offers the most comprehensive selection of off-the-shelf tool kit solutions for professional system integrators and installers, has added the PT-7500 commercial and industrial labeling tool to its 2010 source book catalog offerings.
Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced that it has received a letter from the U.S. Food and Drug Administration informing the company of the approvability of its Premarket Approval Application (PMA) for the Senza spinal cord stimulation (SCS) system.
Treating patients with the new blood thinning medication dabigatran (Pradaxa), instead of warfarin results in significantly higher per patient costs and higher net costs per stroke avoided, according to a new study by pharmacy benefit manager Prime Therapeutics (Prime).The study will be presented today at the Academy of Managed Care Pharmacy's Educational Conference in Atlanta, Ga.
› Verified 8 days ago
| Entity Name | Savida Health, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588226328 PECOS PAC ID: 4082809967 Enrollment ID: O20190807001538 |
News Archive
A new purification process developed by Cook Medical for culture oil used in assisted reproduction eliminates traces of contaminants below detectable limits of 0.1 parts per million. The oil is purified by a proprietary refining technique that removes hydrocarbon impurities, which can have adverse effects on fertilization and threaten the viability of the developing embryos. The culture oil viscosity, MEA and LAL parameters remain unchanged.
Specialized Products Company (SPC), www.specialized.net, which offers the most comprehensive selection of off-the-shelf tool kit solutions for professional system integrators and installers, has added the PT-7500 commercial and industrial labeling tool to its 2010 source book catalog offerings.
Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced that it has received a letter from the U.S. Food and Drug Administration informing the company of the approvability of its Premarket Approval Application (PMA) for the Senza spinal cord stimulation (SCS) system.
Treating patients with the new blood thinning medication dabigatran (Pradaxa), instead of warfarin results in significantly higher per patient costs and higher net costs per stroke avoided, according to a new study by pharmacy benefit manager Prime Therapeutics (Prime).The study will be presented today at the Academy of Managed Care Pharmacy's Educational Conference in Atlanta, Ga.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Calvin P Fuhrmann, MD 24 Portland Rd, Kennebunk, ME 04043-6630 Ph: (207) 985-3726 | Dr Calvin P Fuhrmann, MD 24 Portland Rd, Kennebunk, ME 04043-6630 Ph: (207) 985-3726 |
News Archive
A new purification process developed by Cook Medical for culture oil used in assisted reproduction eliminates traces of contaminants below detectable limits of 0.1 parts per million. The oil is purified by a proprietary refining technique that removes hydrocarbon impurities, which can have adverse effects on fertilization and threaten the viability of the developing embryos. The culture oil viscosity, MEA and LAL parameters remain unchanged.
Specialized Products Company (SPC), www.specialized.net, which offers the most comprehensive selection of off-the-shelf tool kit solutions for professional system integrators and installers, has added the PT-7500 commercial and industrial labeling tool to its 2010 source book catalog offerings.
Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced that it has received a letter from the U.S. Food and Drug Administration informing the company of the approvability of its Premarket Approval Application (PMA) for the Senza spinal cord stimulation (SCS) system.
Treating patients with the new blood thinning medication dabigatran (Pradaxa), instead of warfarin results in significantly higher per patient costs and higher net costs per stroke avoided, according to a new study by pharmacy benefit manager Prime Therapeutics (Prime).The study will be presented today at the Academy of Managed Care Pharmacy's Educational Conference in Atlanta, Ga.
› Verified 8 days ago
Elaine Carlson, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 72 Main St, Kennebunk, ME 04043 Phone: 207-467-8909 Fax: 207-467-8910 | |
Dr. Kurt S Ebrahim, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2 Independence Dr, Kennebunk, ME 04043 Phone: 207-303-3300 Fax: 207-250-2144 | |
Evan Bachman, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 2 Livewell Dr, Kennebunk, ME 04043 Phone: 207-467-8988 | |
John W Thompson, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Livewell Dr, The Medical Group Dept. Of Goodall Hospital, Kennebunk, ME 04043 Phone: 207-985-7174 Fax: 207-985-1304 | |
Paul E Segal, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Livewell Dr, Kennebunk, ME 04043 Phone: 207-467-8988 | |
Dr. William Joseph Cullen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Livewell Drive, Kennebunk, ME 04043 Phone: 207-467-8988 Fax: 207-467-8969 |